Managers / Q1 2019 · view latest →
Informed Momentum Co LLC
CIK 0001510989 · 215 HIGHWAY 101, SUITE 216, SOLANA BEACH, CA, 92075 · 7604795075
Summary
Informed Momentum Co LLC reported $408M in U.S.-listed holdings across 248 positions for Q1 2019.
Its largest position, FLB, represents 1.3% of the portfolio.
Compared with Q4 2018, the fund opened 117 new positions and exited 117.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.6% · $369M
- Other · 6.1% · $25M
- REIT · 3.1% · $13M
- ADR · 0.2% · $869,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2018 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TELARIA INC | NEW | +639.1K | 639.1K | +$4M | $4M |
| TEUMPARETEUM CORPORATI | NEW | +836.1K | 836.1K | +$4M | $4M |
| LSCCLattice Semiconductor Corporation | NEW | +277.4K | 277.4K | +$3M | $3M |
| NMIHNMI Holdings, Inc. | NEW | +126.6K | 126.6K | +$3M | $3M |
| AXSMAXSOME THERAPEUTIC | NEW | +227.2K | 227.2K | +$3M | $3M |
| BIOHAVEN PHARMACEU | NEW | +61.8K | 61.8K | +$3M | $3M |
| G2CEveri Holdings Inc. | NEW | +292.7K | 292.7K | +$3M | $3M |
| TSRAEURXPERI CORP | NEW | +130.5K | 130.5K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | FLBFluidigm Corporationhistory → | Common Stock | 1.26% | $5M | 386.9K |
| 2 | VCYTVeracyte, Inc.history → | Common Stock | 1.21% | $5M | 196.6K |
| 3 | BioDelivery Sciences International, Inc. | Common Stock | 1.12% | $5M | 863.6K |
| 4 | TNDMTandem Diabetes Care, Inc.history → | Common Stock | 1.09% | $4M | 69.9K |
| 5 | CDXSCodexis, Inc.history → | Common Stock | 1.00% | $4M | 199.3K |
| 6 | RUBIEURThe Rubicon Project, Inc.history → | Common Stock | 1.00% | $4M | 671.1K |
| 7 | TELARIA INC | Common Stock | 0.99% | $4M | 639.1K |
| 8 | TEUMPARETEUM CORPORATI | Common Stock | 0.93% | $4M | 836.1K |
| 9 | NEONeogenomics, Inc. | Common Stock | 0.92% | $4M | 182.9K |
| 10 | Invitae Corporation | Common Stock | 0.90% | $4M | 157.4K |
| 11 | EVBGEUREverbridge, Inc. | Common Stock | 0.87% | $4M | 47.5K |
| 12 | LSCCLattice Semiconductor Corporation | Common Stock | 0.81% | $3M | 277.4K |
| 13 | NMIHNMI Holdings, Inc. | Common Stock | 0.80% | $3M | 126.6K |
| 14 | RETAEURReata Pharmaceuticals, Inc. | Common Stock | 0.80% | $3M | 37.9K |
| 15 | AXSMAXSOME THERAPEUTIC | Common Stock | 0.79% | $3M | 227.2K |
| 16 | BIOHAVEN PHARMACEU | Common Stock | 0.78% | $3M | 61.8K |
| 17 | SMPLThe Simply Good Foods Company | Common Stock | 0.76% | $3M | 151.1K |
| 18 | G2CEveri Holdings Inc. | Common Stock | 0.76% | $3M | 292.7K |
| 19 | FRPTFreshpet, Inc. | Common Stock | 0.75% | $3M | 72.4K |
| 20 | TSRAEURXPERI CORP | Common Stock | 0.75% | $3M | 130.5K |
| 21 | AMSCAmerican Superconductor Corporation | Common Stock | 0.75% | $3M | 237.0K |
| 22 | BOOMDMC Global Inc | Common Stock | 0.75% | $3M | 61.4K |
| 23 | ENPHEnphase Energy, Inc. | Common Stock | 0.74% | $3M | 327.4K |
| 24 | NXRTNexPoint Residential Trust, Inc. | Common Stock | 0.73% | $3M | 77.9K |
| 25 | CWSTCasella Waste Systems, Inc. | Common Stock | 0.73% | $3M | 83.8K |
| 26 | CRMTAmerica's Car Mart, Inc. | Common Stock | 0.73% | $3M | 32.6K |
| 27 | LRNUSDK12 Inc. | Common Stock | 0.72% | $3M | 86.3K |
| 28 | MRTXEURMirati Therapeutics, Inc. | Common Stock | 0.71% | $3M | 39.7K |
| 29 | KIDSOrthopediatrics Corp. | Common Stock | 0.70% | $3M | 64.5K |
| 30 | UPLDEURUpland Software, Inc. | Common Stock | 0.70% | $3M | 67.2K |
| 31 | INSPINSPIRE MEDICAL SY | Common Stock | 0.70% | $3M | 50.0K |
| 32 | JYNTThe Joint Corp | Common Stock | 0.68% | $3M | 177.0K |
| 33 | RSTRosetta Stone Inc. | Common Stock | 0.67% | $3M | 125.5K |
| 34 | EHTHeHealth, Inc. | Common Stock | 0.67% | $3M | 44.0K |
| 35 | VCELVericel Corporation | Common Stock | 0.67% | $3M | 155.9K |
| 36 | BANDBandwidth Inc. | Common Stock | 0.66% | $3M | 40.3K |
| 37 | GLUUGLU Mobile Inc. | Common Stock | 0.64% | $3M | 239.8K |
| 38 | APPSDigital Turbine, Inc. | Common Stock | 0.64% | $3M | 746.1K |
| 39 | DENNDenny's Corporation | Common Stock | 0.63% | $3M | 140.4K |
| 40 | CN2Catalyst Pharmaceuticals, Inc. | Common Stock | 0.62% | $3M | 498.8K |
| 41 | AGYSAgilysys, Inc. | Common Stock | 0.62% | $3M | 120.0K |
| 42 | FIVNFive9, Inc. | Common Stock | 0.62% | $3M | 47.8K |
| 43 | NSTGEURNanoString Technologies, Inc. | Common Stock | 0.61% | $2M | 103.4K |
| 44 | DERMEURDermira, Inc. | Common Stock | 0.60% | $2M | 181.5K |
| 45 | CROXCrocs, Inc. | Common Stock | 0.59% | $2M | 93.3K |
| 46 | RPDRapid7, Inc. | Common Stock | 0.58% | $2M | 47.1K |
| 47 | BCRXBioCryst Pharmaceuticals, Inc. | Common Stock | 0.57% | $2M | 287.8K |
| 48 | PCMIPCM, Inc. | Common Stock | 0.57% | $2M | 63.9K |
| 49 | ARRYEURArray BioPharma Inc. | Common Stock | 0.56% | $2M | 94.3K |
| 50 | NSSCNapco Security Technologies, Inc. | Common Stock | 0.56% | $2M | 109.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $866M | 273 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $898M | 268 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $872M | 254 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $660M | 220 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $578M | 246 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $706M | 251 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $669M | 239 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $615M | 241 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $642M | 231 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $564M | 232 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $518M | 271 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $540M | 256 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $454M | 248 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $483M | 249 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $460M | 246 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $410M | 245 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $537M | 270 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $610M | 279 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $593M | 274 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $648M | 302 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $664M | 322 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $611M | 292 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $422M | 263 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $452M | 254 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $322M | 205 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $455M | 242 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $378M | 229 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $409M | 242 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $408M | 248 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $368M | 248 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Bank of New York Mellon Corp028-12592
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.